9 October 2026
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
At the extraordinary Round Table on GMP/GDP on 13 August 2026, Swissmedic and the industry associations clarified unresolved issues on the assessment of GMP compliance by foreign manufacturers in the context of authorisation applications and jointly developed specific solutions and problem-solving approaches.
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: Haemovigilance Annual Report 2025
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
European Medicines Agency: Global regulators call for advancing alternatives to animal testing
-
European Medicines Agency: Highlights of the September 2026 Management Board meeting